Posted 24 July, 2023

Turnstone Biologics Corp. IPO completed

IPO completed detected for ticker Nasdaq:TSBX in a 424B4 filed on 24 July, 2023.

  This is Turnstone Biologics Corp.'s initial public offering.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Turnstone Biologics Corp.
Health Care/Life Sciences • Biotechnology
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It is focused on developing new medicines to treat and cure patients with solid tumors. The company was founded in 2015 and is headquartered in La Jolla, CA.
Market Cap
View Company Details